112 related articles for article (PubMed ID: 9394773)
1. What are the treatment goals for Helicobacter pylori infection?
Fennerty MB
Gastroenterology; 1997 Dec; 113(6 Suppl):S120-5. PubMed ID: 9394773
[TBL] [Abstract][Full Text] [Related]
2. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
3. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
Cutler AF; Vakil N
Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
[TBL] [Abstract][Full Text] [Related]
4. What remaining questions regarding Helicobacter pylori and associated diseases should be addressed by future research? View from North America.
Freston JW
Gastroenterology; 1997 Dec; 113(6 Suppl):S163-6. PubMed ID: 9394780
[TBL] [Abstract][Full Text] [Related]
5. Can therapy even be denied for Helicobacter pylori infection?
Graham DY
Gastroenterology; 1997 Dec; 113(6 Suppl):S113-7. PubMed ID: 9394771
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
[TBL] [Abstract][Full Text] [Related]
7. [Has the discovery of Helicobacter pylori actually made a revolution in gastroenterology?].
Tsimmerman IaS
Klin Med (Mosk); 2013; 91(8):13-21. PubMed ID: 24437178
[TBL] [Abstract][Full Text] [Related]
8. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
[TBL] [Abstract][Full Text] [Related]
10. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
11. What other regimens are under investigation to treat Helicobacter pylori infection?
Unge P
Gastroenterology; 1997 Dec; 113(6 Suppl):S131-48. PubMed ID: 9394775
[TBL] [Abstract][Full Text] [Related]
12. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
Parsonnet J; Harris RA; Hack HM; Owens DK
Lancet; 1996 Jul; 348(9021):150-4. PubMed ID: 8684154
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori: The Past, Present, and Future in Management.
Kamboj AK; Cotter TG; Oxentenko AS
Mayo Clin Proc; 2017 Apr; 92(4):599-604. PubMed ID: 28209367
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Vakil N; Fennerty MB
Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori.
Fennerty MB
Arch Intern Med; 1994 Apr; 154(7):721-7. PubMed ID: 8147675
[TBL] [Abstract][Full Text] [Related]
16. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective?
Breuer T; Graham DY
Am J Gastroenterol; 1999 Mar; 94(3):725-9. PubMed ID: 10086658
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection in Chile.
Figueroa G; Acuña R; Troncoso M; Portell DP; Toledo MS; Valenzuela J
Clin Infect Dis; 1997 Nov; 25(5):983-9. PubMed ID: 9402342
[TBL] [Abstract][Full Text] [Related]
18. Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children.
Kotilea K; Mekhael J; Salame A; Mahler T; Miendje-Deyi VY; Cadranel S; Bontems P
Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28303625
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.
O'Brien B; Goeree R; Mohamed AH; Hunt R
Arch Intern Med; 1995 Oct; 155(18):1958-64. PubMed ID: 7575049
[TBL] [Abstract][Full Text] [Related]
20. Vaccine against Helicobacter pylori: Inevitable approach.
Talebi Bezmin Abadi A
World J Gastroenterol; 2016 Mar; 22(11):3150-7. PubMed ID: 27003991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
